Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Retained Earnings (2017 - 2025)

Selectis Health's Retained Earnings history spans 13 years, with the latest figure at -$21.2 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$21.2 million for Q4 2025, down 5.22% from a year ago — trailing twelve months through Dec 2025 was -$21.2 million (down 5.22% YoY), and the annual figure for FY2025 was -$21.2 million, down 5.22%.
  • Retained Earnings for Q4 2025 was -$21.2 million at Selectis Health, down from -$20.4 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$469302.0 in Q2 2022 to a low of -$21.2 million in Q4 2025.
  • The 5-year median for Retained Earnings is -$13.9 million (2022), against an average of -$14.5 million.
  • The sharpest move saw Retained Earnings soared 95.05% in 2022, then tumbled 2421.78% in 2023.
  • Year by year, Retained Earnings stood at -$11.3 million in 2021, then dropped by 21.43% to -$13.7 million in 2022, then decreased by 29.11% to -$17.7 million in 2023, then fell by 13.79% to -$20.2 million in 2024, then dropped by 5.22% to -$21.2 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$21.2 million, -$20.4 million, and -$21.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.